Global Rifaximin Market Growth 2022-2028
- LP 4798443
- 78 Pages
- January 2022
- Pharmaceuticals
The United States Rifaximin market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Rifaximin market, reaching US$ million by the year 2028. As for the Europe Rifaximin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Rifaximin players cover Salix Pharmaceuticals, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Rifaximin market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
200 mg Tablets
550 mg Tablets
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Drug store
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Salix Pharmaceuticals
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Rifaximin Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Rifaximin by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Rifaximin by Country/Region, 2017, 2022 & 2028
2.2 Rifaximin Segment by Type
2.2.1 200 mg Tablets
2.2.2 550 mg Tablets
2.3 Rifaximin Sales by Type
2.3.1 Global Rifaximin Sales Market Share by Type (2017-2022)
2.3.2 Global Rifaximin Revenue and Market Share by Type (2017-2022)
2.3.3 Global Rifaximin Sale Price by Type (2017-2022)
2.4 Rifaximin Segment by Application
2.4.1 Hospital
2.4.2 Drug store
2.5 Rifaximin Sales by Application
2.5.1 Global Rifaximin Sale Market Share by Application (2017-2022)
2.5.2 Global Rifaximin Revenue and Market Share by Application (2017-2022)
2.5.3 Global Rifaximin Sale Price by Application (2017-2022)
3 Global Rifaximin by Company
3.1 Global Rifaximin Breakdown Data by Company
3.1.1 Global Rifaximin Annual Sales by Company (2020-2022)
3.1.2 Global Rifaximin Sales Market Share by Company (2020-2022)
3.2 Global Rifaximin Annual Revenue by Company (2020-2022)
3.2.1 Global Rifaximin Revenue by Company (2020-2022)
3.2.2 Global Rifaximin Revenue Market Share by Company (2020-2022)
3.3 Global Rifaximin Sale Price by Company
3.4 Key Manufacturers Rifaximin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rifaximin Product Location Distribution
3.4.2 Players Rifaximin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Rifaximin by Geographic Region
4.1 World Historic Rifaximin Market Size by Geographic Region (2017-2022)
4.1.1 Global Rifaximin Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Rifaximin Annual Revenue by Geographic Region
4.2 World Historic Rifaximin Market Size by Country/Region (2017-2022)
4.2.1 Global Rifaximin Annual Sales by Country/Region (2017-2022)
4.2.2 Global Rifaximin Annual Revenue by Country/Region
4.3 Americas Rifaximin Sales Growth
4.4 APAC Rifaximin Sales Growth
4.5 Europe Rifaximin Sales Growth
4.6 Middle East & Africa Rifaximin Sales Growth
5 Americas
5.1 Americas Rifaximin Sales by Country
5.1.1 Americas Rifaximin Sales by Country (2017-2022)
5.1.2 Americas Rifaximin Revenue by Country (2017-2022)
5.2 Americas Rifaximin Sales by Type
5.3 Americas Rifaximin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rifaximin Sales by Region
6.1.1 APAC Rifaximin Sales by Region (2017-2022)
6.1.2 APAC Rifaximin Revenue by Region (2017-2022)
6.2 APAC Rifaximin Sales by Type
6.3 APAC Rifaximin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Rifaximin by Country
7.1.1 Europe Rifaximin Sales by Country (2017-2022)
7.1.2 Europe Rifaximin Revenue by Country (2017-2022)
7.2 Europe Rifaximin Sales by Type
7.3 Europe Rifaximin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Rifaximin by Country
8.1.1 Middle East & Africa Rifaximin Sales by Country (2017-2022)
8.1.2 Middle East & Africa Rifaximin Revenue by Country (2017-2022)
8.2 Middle East & Africa Rifaximin Sales by Type
8.3 Middle East & Africa Rifaximin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rifaximin
10.3 Manufacturing Process Analysis of Rifaximin
10.4 Industry Chain Structure of Rifaximin
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rifaximin Distributors
11.3 Rifaximin Customer
12 World Forecast Review for Rifaximin by Geographic Region
12.1 Global Rifaximin Market Size Forecast by Region
12.1.1 Global Rifaximin Forecast by Region (2023-2028)
12.1.2 Global Rifaximin Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Rifaximin Forecast by Type
12.7 Global Rifaximin Forecast by Application
13 Key Players Analysis
13.1 Salix Pharmaceuticals
13.1.1 Salix Pharmaceuticals Company Information
13.1.2 Salix Pharmaceuticals Rifaximin Product Offered
13.1.3 Salix Pharmaceuticals Rifaximin Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Salix Pharmaceuticals Main Business Overview
13.1.5 Salix Pharmaceuticals Latest Developments
14 Research Findings and Conclusion
Table 1. Rifaximin Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Rifaximin Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 200 mg Tablets
Table 4. Major Players of 550 mg Tablets
Table 5. Global Rifaximin Sales by Type (2017-2022) & (K Units)
Table 6. Global Rifaximin Sales Market Share by Type (2017-2022)
Table 7. Global Rifaximin Revenue by Type (2017-2022) & ($ million)
Table 8. Global Rifaximin Revenue Market Share by Type (2017-2022)
Table 9. Global Rifaximin Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Rifaximin Sales by Application (2017-2022) & (K Units)
Table 11. Global Rifaximin Sales Market Share by Application (2017-2022)
Table 12. Global Rifaximin Revenue by Application (2017-2022)
Table 13. Global Rifaximin Revenue Market Share by Application (2017-2022)
Table 14. Global Rifaximin Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Rifaximin Sales by Company (2020-2022) & (K Units)
Table 16. Global Rifaximin Sales Market Share by Company (2020-2022)
Table 17. Global Rifaximin Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Rifaximin Revenue Market Share by Company (2020-2022)
Table 19. Global Rifaximin Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Rifaximin Producing Area Distribution and Sales Area
Table 21. Players Rifaximin Products Offered
Table 22. Rifaximin Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Rifaximin Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Rifaximin Sales Market Share Geographic Region (2017-2022)
Table 27. Global Rifaximin Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Rifaximin Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Rifaximin Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Rifaximin Sales Market Share by Country/Region (2017-2022)
Table 31. Global Rifaximin Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Rifaximin Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Rifaximin Sales by Country (2017-2022) & (K Units)
Table 34. Americas Rifaximin Sales Market Share by Country (2017-2022)
Table 35. Americas Rifaximin Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Rifaximin Revenue Market Share by Country (2017-2022)
Table 37. Americas Rifaximin Sales by Type (2017-2022) & (K Units)
Table 38. Americas Rifaximin Sales Market Share by Type (2017-2022)
Table 39. Americas Rifaximin Sales by Application (2017-2022) & (K Units)
Table 40. Americas Rifaximin Sales Market Share by Application (2017-2022)
Table 41. APAC Rifaximin Sales by Region (2017-2022) & (K Units)
Table 42. APAC Rifaximin Sales Market Share by Region (2017-2022)
Table 43. APAC Rifaximin Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Rifaximin Revenue Market Share by Region (2017-2022)
Table 45. APAC Rifaximin Sales by Type (2017-2022) & (K Units)
Table 46. APAC Rifaximin Sales Market Share by Type (2017-2022)
Table 47. APAC Rifaximin Sales by Application (2017-2022) & (K Units)
Table 48. APAC Rifaximin Sales Market Share by Application (2017-2022)
Table 49. Europe Rifaximin Sales by Country (2017-2022) & (K Units)
Table 50. Europe Rifaximin Sales Market Share by Country (2017-2022)
Table 51. Europe Rifaximin Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Rifaximin Revenue Market Share by Country (2017-2022)
Table 53. Europe Rifaximin Sales by Type (2017-2022) & (K Units)
Table 54. Europe Rifaximin Sales Market Share by Type (2017-2022)
Table 55. Europe Rifaximin Sales by Application (2017-2022) & (K Units)
Table 56. Europe Rifaximin Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Rifaximin Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Rifaximin Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Rifaximin Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Rifaximin Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Rifaximin Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Rifaximin Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Rifaximin Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Rifaximin Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Rifaximin
Table 66. Key Market Challenges & Risks of Rifaximin
Table 67. Key Industry Trends of Rifaximin
Table 68. Rifaximin Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Rifaximin Distributors List
Table 71. Rifaximin Customer List
Table 72. Global Rifaximin Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Rifaximin Sales Market Forecast by Region
Table 74. Global Rifaximin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Rifaximin Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Rifaximin Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Rifaximin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Rifaximin Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Rifaximin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Rifaximin Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Rifaximin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Rifaximin Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Rifaximin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Rifaximin Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Rifaximin Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Rifaximin Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Rifaximin Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Rifaximin Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Rifaximin Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Rifaximin Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Rifaximin Revenue Market Share Forecast by Application (2023-2028)
Table 92. Salix Pharmaceuticals Basic Information, Rifaximin Manufacturing Base, Sales Area and Its Competitors
Table 93. Salix Pharmaceuticals Rifaximin Product Offered
Table 94. Salix Pharmaceuticals Rifaximin Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Salix Pharmaceuticals Main Business
Table 96. Salix Pharmaceuticals Latest Developments
List of Figures
Figure 1. Picture of Rifaximin
Figure 2. Rifaximin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rifaximin Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Rifaximin Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Rifaximin Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 200 mg Tablets
Figure 10. Product Picture of 550 mg Tablets
Figure 11. Global Rifaximin Sales Market Share by Type in 2021
Figure 12. Global Rifaximin Revenue Market Share by Type (2017-2022)
Figure 13. Rifaximin Consumed in Hospital
Figure 14. Global Rifaximin Market: Hospital (2017-2022) & (K Units)
Figure 15. Rifaximin Consumed in Drug store
Figure 16. Global Rifaximin Market: Drug store (2017-2022) & (K Units)
Figure 17. Global Rifaximin Sales Market Share by Application (2017-2022)
Figure 18. Global Rifaximin Revenue Market Share by Application in 2021
Figure 19. Rifaximin Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Rifaximin Revenue Market Share by Company in 2021
Figure 21. Global Rifaximin Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Rifaximin Revenue Market Share by Geographic Region in 2021
Figure 23. Global Rifaximin Sales Market Share by Region (2017-2022)
Figure 24. Global Rifaximin Revenue Market Share by Country/Region in 2021
Figure 25. Americas Rifaximin Sales 2017-2022 (K Units)
Figure 26. Americas Rifaximin Revenue 2017-2022 ($ Millions)
Figure 27. APAC Rifaximin Sales 2017-2022 (K Units)
Figure 28. APAC Rifaximin Revenue 2017-2022 ($ Millions)
Figure 29. Europe Rifaximin Sales 2017-2022 (K Units)
Figure 30. Europe Rifaximin Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Rifaximin Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Rifaximin Revenue 2017-2022 ($ Millions)
Figure 33. Americas Rifaximin Sales Market Share by Country in 2021
Figure 34. Americas Rifaximin Revenue Market Share by Country in 2021
Figure 35. United States Rifaximin Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Rifaximin Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Rifaximin Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Rifaximin Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Rifaximin Sales Market Share by Region in 2021
Figure 40. APAC Rifaximin Revenue Market Share by Regions in 2021
Figure 41. China Rifaximin Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Rifaximin Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Rifaximin Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Rifaximin Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Rifaximin Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Rifaximin Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Rifaximin Sales Market Share by Country in 2021
Figure 48. Europe Rifaximin Revenue Market Share by Country in 2021
Figure 49. Germany Rifaximin Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Rifaximin Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Rifaximin Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Rifaximin Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Rifaximin Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Rifaximin Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Rifaximin Revenue Market Share by Country in 2021
Figure 56. Egypt Rifaximin Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Rifaximin Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Rifaximin Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Rifaximin Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Rifaximin Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Rifaximin in 2021
Figure 62. Manufacturing Process Analysis of Rifaximin
Figure 63. Industry Chain Structure of Rifaximin
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
